Sclerostin Antibody Reverses the Severe Sublesional Bone Loss in Rats After Chronic Spinal Cord Injury

To date, no efficacious therapy exists that will prevent or treat the severe osteoporosis in individuals with neurologically motor-complete spinal cord injury (SCI). Recent preclinical studies have demonstrated that sclerostin antibody (Scl-Ab) can prevent sublesional bone loss after acute SCI in ra...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Calcif Tissue Int
Glavni autori: Zhao, Wei, Li, Xiaodong, Peng, Yuanzhen, Qin, Yiwen, Pan, Jiangping, Li, Jiliang, Xu, Aihua, Ominsky, Michael S., Cardozo, Christopher, Feng, Jian Q., Ke, Hua Zhu, Bauman, William A., Qin, Weiping
Format: Artigo
Jezik:Inglês
Izdano: 2018
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7891854/
https://ncbi.nlm.nih.gov/pubmed/29931461
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00223-018-0439-8
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items